pharmacopeia

Injection Site Bruising

28 drugs22,489 FAERS reportsMedDRA PT
GET
/api/v1/reaction/injection-site-bruising
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.

Drugs reporting Injection Site Bruising (28)

Share = reports listing this reaction ÷ total matched reports for the drug. means the upstream totals query failed at ingest and the denominator is unknown.

  1. 1Hemp17.7%
  2. 2Setmelanotide186.8%
  3. 3Tesamorelin855.6%
  4. 4Asfotase Alfa4815.1%
  5. 5Teriparatide4,7684.3%
  6. 6Zilucoplan274.0%
  7. 7Abaloparatide9843.9%
  8. 8Caplacizumab593.6%
  9. 9Collagenase Clostridium Histolyticum1913.5%
  10. 10Exenatide1,8433.5%
  11. 11Sibeprenlimab23.5%
  12. 12Alirocumab8483.4%
  13. 13Pegvisomant1393.4%
  14. 14Lenacapavir133.1%
  15. 15Evolocumab4,6322.9%
  16. 16Olezarsen122.9%
  17. 17Collagenase1912.8%
  18. 18Peginterferon Beta-1a3482.7%
  19. 19Pegvaliase2102.7%
  20. 20Donidalorsen42.5%
  21. 21Tirzepatide3,2662.3%
  22. 22Interferon Beta-1b4392.3%
  23. 23Galcanezumab6842.3%
  24. 24Dulaglutide1,9302.2%
  25. 25Glatiramer1,2702.1%
  26. 26Mecasermin162.0%
  27. 27Somatrogon191.6%
  28. 28Mirikizumab91.2%

Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.

Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.

Search pharmacopeia

Search drugs, classes, and ingredients